Jan 8 • 23:32 UTC 🇪🇸 Spain ABC

More than 1 in 4 adults could benefit from new anti-obesity drugs

A study suggests implementing strategic programs for GLP-1 medications to address the global obesity crisis, while also warning about the rebound effect of drugs like Ozempic.

📡 Similar Coverage